CORRESP Filing
CollPlant Biotechnologies Ltd
Date: July 1, 2025 · CIK: 0001631487 · Accession: 0001213900-25-060354
AI Filing Summary & Sentiment
File numbers found in text: 333-288109
Show Raw Text
CORRESP 1 filename1.htm CollPlant Biotechnologies Ltd. 4 Oppenheimer, Weizmann Science Park Rehovot 7670104, Israel July 1, 2025 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: CollPlant Biotechnologies Ltd. Registration Statement on Form F-1 File No. 333-288109 VIA EDGAR Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, CollPlant Biotechnologies Ltd. (the " Registrant ") hereby respectfully requests that the effectiveness of the Registration Statement on Form F-1 (File No. 333-288109) of the Registrant (the " Registration Statement ") be accelerated so that the Company's Registration Statement will be declared effective at 4:30 p.m., Eastern Time, on July 3, 2025 or as soon thereafter as may be practicable. The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, LLP, by calling Gary Emmanuel at (212) 801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration. Very truly yours, COLLPLANT BIOTECHNOLOGIES LTD. By: /s/ Eran Rotem Name: Title: Eran Rotem Deputy CEO and Chief Financial Officer cc: Gary Emmanuel (Greenberg Traurig, LLP)